Company Filing History:
Years Active: 2013
Title: The Innovations of Stefan Mahrhold
Introduction
Stefan Mahrhold is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of neurotoxin research. His work has implications for various medical applications, showcasing the importance of innovation in science.
Latest Patents
Stefan Mahrhold holds a patent for a groundbreaking invention titled "Botulinum neurotoxin A protein receptor and uses thereof." This patent involves an isolated polypeptide of the luminal domain of synaptic vesicle glycoprotein 2C, wherein at least 70 percent of the amino acid sequence is identical to the amino acid sequence of SV2C. The polypeptide is designed to bind the H fragment of botulinum neurotoxin A, provided that it is not the synaptic vesicle glycoprotein 2C.
Career Highlights
Mahrhold's career is marked by his dedication to advancing the understanding of neurotoxins and their applications. His work at Toxogen GmbH has positioned him as a key figure in the biotechnology sector. His innovative approach has led to the development of new therapeutic strategies.
Collaborations
Stefan Mahrhold has collaborated with esteemed colleagues such as Johannes Wilhelm Bigalke and Andreas Rummel. These partnerships have fostered a collaborative environment that enhances research and development efforts in their field.
Conclusion
Stefan Mahrhold's contributions to biotechnology, particularly through his patent on botulinum neurotoxin A, highlight the critical role of inventors in advancing medical science. His work continues to inspire innovation and collaboration in the industry.